Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004358 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Calcitonin for Tumoral Calcinosis
A Phase 2 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00004358 is a Phase 2 study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 9 participants.
The verdict
NCT00004358, a Phase 2 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine whether intermittent, long-term, subcutaneous administration of calcitonin increases phosphaturia, reduces hyperphosphatemia, and increases intact parathyroid hormone levels in patients with tumoral calcinosis. II. Determine whether calcitonin reduces or prevents tumor recurrence. III. Determine whether hyperphosphatemia abolishes the normal circadian pattern of serum phosphorus. IV. Determine how repetitive calcitonin administration alters the biochemical markers of bone metabolism in osteopenic patients with tumoral calcinosis.
Interventions
- DRUG calcitonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 1992-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004358
The ClinicalTrials.gov registry entry for NCT00004358 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which calcitonin is the first listed.
NCT00004358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004358 about?
NCT00004358 is a clinical study titled "Phase II Study of Calcitonin for Tumoral Calcinosis". OBJECTIVES: I. Determine whether intermittent, long-term, subcutaneous administration of calcitonin increases phosphaturia, reduces hyperphosphatemia, and increases intact parathyroid hormone levels in patients with tumoral calcinosis. II. Determine whether calcitonin reduces or prevents tumor recu...
What is the current status of trial NCT00004358?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 1992-11.
What interventions are being tested in trial NCT00004358?
The interventions under investigation include: calcitonin (DRUG).
Who is sponsoring clinical trial NCT00004358?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.